Venture Capital
Paris, Île-de-France, 75003
Want more details about this investor? Join now for instant access!
We are a thesis-driven venture capital firm that backs founders on a mission to industrialize technological progress. With the new round, Atmio will accelerate deployments of its OS that helps natural gas operators find, fix, and report methane leaks. Orakl announces seed round to accelerate cancer drug development with techbio platform that better models tumors. Founded by former Apple and Palantir engineers, the company develops dual-use autonomous surveillance towers powered by AI.
111224sbs